Sign in
8-K

Current Report

Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-245186

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d111506d8k.htm…